Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity
Open Access
- 1 December 2000
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 165 (11), 6635-6643
- https://doi.org/10.4049/jimmunol.165.11.6635
Abstract
Signaling thresholds influence the balance between humoral immunity and autoimmunity. Cell surface CD19 regulates intrinsic and Ag receptor-induced B lymphocyte signaling thresholds, and transgenic mice that overexpress CD19 by 3-fold generate spontaneous autoantibodies in a genetic background not associated with autoimmunity. To quantify the extent that genetically determined differences in expression of a single cell surface molecule can influence autoantibody production, we have assessed autoimmunity in a C57BL/6-transgenic mouse line with subtle 15–29% increases in CD19 cell surface expression (CD19 transgenic). Antinuclear Abs, especially anti-spindle pole Abs, rheumatoid factor, and autoantibodies for ssDNA, dsDNA, and histone were produced in these transgenic mice, but not littermate controls. This demonstrates that small changes in CD19 expression can induce autoantibody production. Remarkably, similar changes in CD19 expression were found on B cells from patients with systemic sclerosis, a multisystem disorder of connective tissue with autoantibody production. CD19 density on blood B cells from systemic sclerosis patients was significantly (∼20%) higher compared with normal individuals, whereas CD20, CD22, and CD40 expression were normal. These results suggest that modest changes in the expression or function of regulatory molecules such as CD19 may shift the balance between tolerance and immunity to autoimmunity. Thereby autoimmune disease may result from a collection of subtle multigenic alterations that could include incremental density changes in cell surface signaling molecules.Keywords
This publication has 37 references indexed in Scilit:
- The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and AutoimmunityImmunity, 1997
- Antiubiquitin antibody in localised and systemic scleroderma.Annals Of The Rheumatic Diseases, 1996
- The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural to Acquired ImmunityAnnual Review of Immunology, 1995
- Antihistone Antibodies in Systemic SclerosisArthritis & Rheumatism, 1994
- Antihistone antibodies in patients with localized sclerodermaArthritis & Rheumatism, 1993
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Antinuclear Antibodies and Anti‐DNA Antibodies in SclerodermaAllergy, 1986
- Human anticentriole autoantibody in patients with scleroderma and Raynaud's phenomenonClinical Immunology and Immunopathology, 1983
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949